Clinical Trial Update: Pharmacokinetics, Safety, and Efficacy of SPRIX in 12 to 17 Year Old Patients vs. Adult Patients Undergoing Open Surgical Procedures [Phase 3]

View source ↗

Summary

Completed Phase 3 study evaluating pharmacokinetics, safety, and efficacy of SPRIX in adolescents (12-17) versus adults undergoing open surgical procedures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• SPRIX (ketorolac tromethamine)

Snippet

Sponsor: American Regent, Inc. | Conditions: Pain | Phase 3 | Status: COMPLETED